HPV vaccine was previously thought to be safe only for young girls, but now it was found to protect even adult women from cervical cancer, reveals a new study.
No link was found between human papillomavirus (HPV) vaccination and 44 serious chronic diseases. The study was conducted in more than 3 million Danish and Swedish adult women and published in Journal of Internal Medicine.
Combining Traditional Education With Incentives can Help Improve HPV Vaccination Rates
A new study reveals that combining traditional education with quality improvement and incentives can help improve Human Papilloma virus vaccination rates.
Advertisement
‘HPV immunization programs mainly target girls who are in the age group of 9 and 12 and adult women through catch-up programs.’
Tweet it Now
The authors did report an increased risk of developing celiac disease an autoimmune condition triggered by dietary gluten; however, the increased risk was only observed in Denmark.
Because previous research has shown that celiac disease is markedly underdiagnosed in the general adult population in Denmark.
The findings may be due to unmasking of pre-existing celiac disease. No other serious safety concerns were found.
![Non-completion of HPV Vaccination in Girls in Low-income Families]( "Non-completion of HPV Vaccination in Girls in Low-income Families")
Although they are at higher risk for cervical cancer, girls from low-income families are less likely to receive the human papillomavirus (HPV) vaccine that prevents
Because HPV immunization programs target girls aged 9 to 12 years, the majority of post-licensure evidence of the safety of HPV vaccines comes from young adolescents; however, adult women are also getting HPV vaccinated through catch-up programs or by choice at their own expenses.
"This is the most comprehensive study of HPV vaccination safety in adult women to date. It is not unreasonable to expect different safety concerns in adult women compared with young girls, and our study is an important supplement to the safety studies in young girls," said lead author Dr. Anders Hviid, of the Statens Serum Institut, in Denmark.
Source: Eurekalert
The findings may be due to unmasking of pre-existing celiac disease. No other serious safety concerns were found.
Non-completion of HPV Vaccination in Girls in Low-income Families
Although they are at higher risk for cervical cancer, girls from low-income families are less likely to receive the human papillomavirus (HPV) vaccine that prevents
Advertisement
Because HPV immunization programs target girls aged 9 to 12 years, the majority of post-licensure evidence of the safety of HPV vaccines comes from young adolescents; however, adult women are also getting HPV vaccinated through catch-up programs or by choice at their own expenses.
"This is the most comprehensive study of HPV vaccination safety in adult women to date. It is not unreasonable to expect different safety concerns in adult women compared with young girls, and our study is an important supplement to the safety studies in young girls," said lead author Dr. Anders Hviid, of the Statens Serum Institut, in Denmark.
Source: Eurekalert
Implementation of HPV Vaccinations At A Young Age Is Important For Its Effectiveness: Study
According to a Swedish study initial vaccinations for human papillomavirus (HPV) at a young age is important for maximizing quadrivalent HPV vaccine effectiveness.
Advertisement
 Low Completion Levels of HPV Vaccination Underlines Lack of Patient Education and Vaccine ProgramsResearchers at University of Texas Medical Branch (UTMB) have underlined the lack of patient education and public vaccine financing programs. | Advertisement
|
Advertisement
Recommended Readings
Latest Women Health News
Cardiovascular rehabilitation, which lowers mortality and readmission rates, is underutilized and less effective in women than in men.
Laser speckle wearable gadget helps in the early detection of postpartum hemorrhage, potentially reducing maternal mortality rates.
More than 90% of previously unexplained pregnancy losses or miscarriages were accurately determined by placental testing.
Fetal growth restriction impacts around 60,000 infants annually in Europe and the United States.
For women under 40, trying to conceive, timing intercourse around the fertile period using a urine ovulation test increases the chances of pregnancy.
